The New Yorker

Sam Altman May Control Our Future—Can He Be Trusted?

For weeks, they’d been having furtive discussions about whether Sam Altman, OpenAI’s C.E.O., and Greg Brockman, his second-in ...
The New Yorker

Sam Altman’s Trust Issues at OpenAI | The New Yorker Radio Hour

OpenAI existed for why it needed to exist, there's this constant thread of analogies to the Manhattan Project. So when he ...

Matcha model makes drug candidate screening more than 30 times faster

Ligand Pro, founded by Skoltech professors and a Skoltech Ph.D. student, has presented Matcha, an AI-powered molecular docking model that performs virtual drug screening 30 times faster than the large ...

Universal Music Group: What Bill Ackman's Takeover Means For Investors (Rating Downgrade)

Universal Music Group faces a Pershing Square merger bid and NYSE relisting risk. See why growth and leverage concerns ...